Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1946
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 4
1970 3
1975 1
1985 2
1987 2
1988 4
1990 5
1991 2
1992 1
1993 1
1995 2
1997 2
2000 1
2001 4
2002 3
2003 2
2004 2
2005 3
2006 3
2007 2
2008 3
2009 2
2011 1
2013 1
2014 1
2015 2
2017 2
2018 5
2019 8
2020 5
2021 14
2022 8
2023 11
2024 8
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for brescia f
Search for Crescia F instead (1 results)
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, Gelber RD, de Azambuja E, Fielding A, Balmaña J, Domchek SM, Gelmon KA, Hollingsworth SJ, Korde LA, Linderholm B, Bandos H, Senkus E, Suga JM, Shao Z, Pippas AW, Nowecki Z, Huzarski T, Ganz PA, Lucas PC, Baker N, Loibl S, McConnell R, Piccart M, Schmutzler R, Steger GG, Costantino JP, Arahmani A, Wolmark N, McFadden E, Karantza V, Lakhani SR, Yothers G, Campbell C, Geyer CE Jr; OlympiA Clinical Trial Steering Committee and Investigators. Tutt ANJ, et al. N Engl J Med. 2021 Jun 24;384(25):2394-2405. doi: 10.1056/NEJMoa2105215. Epub 2021 Jun 3. N Engl J Med. 2021. PMID: 34081848 Free PMC article. Clinical Trial.
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Geyer CE Jr, Garber JE, Gelber RD, Yothers G, Taboada M, Ross L, Rastogi P, Cui K, Arahmani A, Aktan G, Armstrong AC, Arnedos M, Balmaña J, Bergh J, Bliss J, Delaloge S, Domchek SM, Eisen A, Elsafy F, Fein LE, Fielding A, Ford JM, Friedman S, Gelmon KA, Gianni L, Gnant M, Hollingsworth SJ, Im SA, Jager A, Jóhannsson ÓÞ, Lakhani SR, Janni W, Linderholm B, Liu TW, Loman N, Korde L, Loibl S, Lucas PC, Marmé F, Martinez de Dueñas E, McConnell R, Phillips KA, Piccart M, Rossi G, Schmutzler R, Senkus E, Shao Z, Sharma P, Singer CF, Španić T, Stickeler E, Toi M, Traina TA, Viale G, Zoppoli G, Park YH, Yerushalmi R, Yang H, Pang D, Jung KH, Mailliez A, Fan Z, Tennevet I, Zhang J, Nagy T, Sonke GS, Sun Q, Parton M, Colleoni MA, Schmidt M, Brufsky AM, Razaq W, Kaufman B, Cameron D, Campbell C, Tutt ANJ; OlympiA Clinical Trial Steering Committee and Investigators. Geyer CE Jr, et al. Ann Oncol. 2022 Dec;33(12):1250-1268. doi: 10.1016/j.annonc.2022.09.159. Epub 2022 Oct 10. Ann Oncol. 2022. PMID: 36228963 Free PMC article. Clinical Trial.
Gold: not just jewelry….
Brescia F, Ronconi L. Brescia F, et al. Future Med Chem. 2023 Apr;15(8):647-650. doi: 10.4155/fmc-2023-0078. Epub 2023 May 11. Future Med Chem. 2023. PMID: 37166073
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Terminology for vascular access devices.
Iacobone E, Brescia F, Capozzoli G, Elisei D, Giustivi D, Greca ALA, Pinelli F, Pittiruti M. Iacobone E, et al. Among authors: brescia f. J Vasc Surg. 2021 Jul;74(1):344-345. doi: 10.1016/j.jvs.2020.12.114. J Vasc Surg. 2021. PMID: 34172194 Free PMC article. No abstract available.
Melanoma of the head and neck.
Day TA, Hornig JD, Sharma AK, Brescia F, Gillespie MB, Lathers D. Day TA, et al. Among authors: brescia f. Curr Treat Options Oncol. 2005 Jan;6(1):19-30. doi: 10.1007/s11864-005-0010-5. Curr Treat Options Oncol. 2005. PMID: 15610712 Review.
Palliative care in pancreatic cancer.
Brescia FJ. Brescia FJ. Cancer Control. 2004 Jan-Feb;11(1):39-45. doi: 10.1177/107327480401100206. Cancer Control. 2004. PMID: 14749622 Free article. Review.
105 results